Histochemical Analysis of Lacrimal Concretions in a Patient Using Rebamipide Ophthalmic Suspension: Case Report
Open Access
- 15 February 2021
- journal article
- medicine
- Published by Springer Science and Business Media LLC in SN Comprehensive Clinical Medicine
- Vol. 3 (4), 1047-1052
- https://doi.org/10.1007/s42399-021-00810-w
Abstract
Concretions of the lacrimal drainage system can cause dacryocystitis. In the present study, our patient developed dacryocystisis with lacrimal concretions of a white soft mass. Rebamipide ophthalmic suspension had been applied for treatment of dry eye. To evaluate the pathogenic mechanism of the case, histological and chemical studies were performed. Our case was woman in her seventies. She had a medical history of rheumatoid arthritis. She was referred to our hospital for dacryocystitis after showing a poor response to treatment with antibiotic agents. A head computed tomography (CT) scan showed ductal high-density deposits along the lacrimal sacs. During dacryocystotomy, the hypertrophy of the lacrimal sacs was found replete with pus and cottage cheese-like white substances. The extracts were surgically removed, and histological and chemical analysis was performed. The histological examination showed granulation tissues and acellular amorphous material with crystal-like structures. Positive staining by Alcian blue and Kossa was found in crystal-like legions. The extract obtained from the concretions showed the same fluorescence band and UV absorption spectrum in thin layer chromatography (TLC) and spectrometry, respectively, as rebamipide. Our findings suggest that the obstruction by lacrimal concretions containing rebamipide resulted in dacryocystitis in this case. In addition, it is speculated that in patients who have impaired tear secretion, refractory dacryocystitis may be evoked following the accumulation of rebamipide in the lacrimal sacs.Keywords
This publication has 11 references indexed in Scilit:
- Effect of topical rebamipide on goblet cells in the lid wiper of human conjunctivaExperimental and Therapeutic Medicine, 2017
- Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cellsBritish Journal of Ophthalmology, 2013
- Protection of Human Corneal Epithelial Cells From TNF-α–Induced Disruption of Barrier Function by RebamipideInvestigative Ophthalmology & Visual Science, 2013
- A Randomized, Multicenter Phase 3 Study Comparing 2% Rebamipide (OPC-12759) with 0.1% Sodium Hyaluronate in the Treatment of Dry EyeOphthalmology, 2013
- Functions of ocular surface mucins in health and diseaseCurrent Opinion in Allergy and Clinical Immunology, 2008
- Rebamipide Increases the Amount of Mucin-like Substances on the Conjunctiva and Cornea in the N-Acetylcysteine-Treated In Vivo ModelCornea, 2004
- Clinicopathologic Findings From Lacrimal Sac Biopsy Specimens Obtained During DacryocystorhinostomyOphthalmic Plastic & Reconstructive Surgery, 2003
- Dacryoliths in chronic dacryocystitis and their composition (spectrophotometric analysis).European Journal of Ophthalmology, 1999
- Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in ratsDigestive Diseases and Sciences, 1993
- The Dacryolithiasis SyndromeOphthalmic Plastic & Reconstructive Surgery, 1988